Cargando…

Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness

Hypersexuality is a well-known adverse side effect of dopamine replacement therapy (DRT), and anti-craving drugs could be an effective therapeutic option. Our aim was to update the knowledge on this issue, particularly on the influence of an Opioid Receptor Mu 1 (OPRM1) genetic polymorphism. A syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verholleman, Audrey, Victorri-Vigneau, Caroline, Laforgue, Edouard, Derkinderen, Pascal, Verstuyft, Celine, Grall-Bronnec, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215378/ https://www.ncbi.nlm.nih.gov/pubmed/32344532 http://dx.doi.org/10.3390/ijms21083002

Ejemplares similares

Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review
por: Grall-Bronnec, Marie, et al.
Publicado: (2016)

Dopamine Agonists and Impulse Control Disorders: A Complex Association
por: Grall-Bronnec, Marie, et al.
Publicado: (2017)

Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges
por: Schreck, Benoit, et al.
Publicado: (2020)

Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance data
por: Laforgue, Edouard-Jules, et al.
Publicado: (2023)

Do older people know why they take benzodiazepines? A national French cross‐sectional survey of long‐term consumers
por: Laforgue, Edouard‐Jules, et al.
Publicado: (2020)

Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
por: Laforgue, Edouard-Jules, et al.
Publicado: (2022)

Parkinson's disease and iatrogenic impulsive-compulsive behaviors: A case/non-case study to build a complete model of individual vulnerability
por: Grall-Bronnec, Marie, et al.
Publicado: (2022)

What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report
por: Guillou-Landreat, Morgane, et al.
Publicado: (2021)

Prevalence of Coaddictions and Rate of Successful Treatment Among a French Sample of Opioid-Dependent Patients With Long-Term Opioid Substitution Therapy: The OPAL Study
por: Grall-Bronnec, Marie, et al.
Publicado: (2019)

Bipolar disorder and adherence: implications of manic subjective experience on treatment disruption
por: Bulteau, Samuel, et al.
Publicado: (2018)

How do people who use drugs receiving Opioid Medication Therapy perceive their treatment ? A multicentre study
por: Guillou Landreat, Morgane, et al.
Publicado: (2022)

Cognitive Remediation Interventions for Gambling Disorder: A Systematic Review
por: Challet-Bouju, Gaëlle, et al.
Publicado: (2017)

Fortune telling addiction: Unfortunately a serious topic. About a case report
por: GRALL-BRONNEC, MARIE, et al.
Publicado: (2015)

Opioid Antagonists for Pharmacological Treatment of Gambling Disorder: Are they Relevant?
por: Victorri-Vigneau, Caroline, et al.
Publicado: (2018)

French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol
por: Gérardin, Marie, et al.
Publicado: (2019)

Regulatory Framework Implementation for the Prescription of Zolpidem in France, What Impact in the Older People?
por: Jobert, Alexandra, et al.
Publicado: (2021)

High prevalence of kaolin consumption in migrant women living in a major urban area of France: A cross-sectional investigation
por: Caillet, Pascal, et al.
Publicado: (2019)

Objectivation of the Equimolar Mixture of Oxygen and Nitrous Oxide Anxiolytic Effect in Pediatric Dentistry: A Pilot Study
por: Clouet, Roselyne, et al.
Publicado: (2023)

Inpatient Gamma-Hydroxybutyrate Detoxification: A Case Report Describing Day-to-day Therapeutic Management
por: von Theobald, Louis, et al.
Publicado: (2017)

A Comparison of Treatment-Seeking Behavioral Addiction Patients with and without Parkinson’s Disease
por: Sauvaget, Anne, et al.
Publicado: (2017)

French Experience with Buprenorphine : Do Physicians Follow the Guidelines?
por: Guillou Landreat, Morgane, et al.
Publicado: (2015)

Did the New French Regulation of Zolpidem Decrease the Problematic Consumption of Zolpidem? A Field Study among Users
por: Laforgue, Edouard-Jules, et al.
Publicado: (2022)

Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype
por: Ziauddeen, Hisham, et al.
Publicado: (2016)

Hypersexual Disorder According to the Hypersexual Disorder Screening Inventory in Help-Seeking Swedish Men and Women With Self-Identified Hypersexual Behavior
por: Öberg, Katarina Görts, et al.
Publicado: (2017)

Prevalence of hypersexual behavior in Parkinson’s disease patients: Not restricted to males and dopamine agonist use
por: Cooper, Christine A, et al.
Publicado: (2009)

Nitrous oxide: a unique official French addictovigilance national survey
por: Guerlais, Marylène, et al.
Publicado: (2023)

French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change
por: Aquizerate, Aurélie, et al.
Publicado: (2023)

Assessment of an Equimolar Mixture of Oxygen and Nitrous Oxide: Effects in Pediatric Dentistry
por: Prud’homme, Tony, et al.
Publicado: (2019)

Abstinence from Masturbation and Hypersexuality
por: Zimmer, Felix, et al.
Publicado: (2020)

The role of negative mood states and consequences of hypersexual behaviours in predicting hypersexuality among university students
por: Dhuffar, Manpreet K., et al.
Publicado: (2015)

An analysis of the effect of mu-opioid receptor gene (OPRM1) promoter region DNA methylation on the response of naltrexone treatment of alcohol dependence
por: Lin, Yufei, et al.
Publicado: (2020)

Associations of the A118G OPRM1 polymorphism with sociotropy and interpersonal sensitivity
por: Suzuki, Akihito, et al.
Publicado: (2022)

Aripiprazol and Hypersexuality: when partial is to much
por: Espada-Santos, P., et al.
Publicado: (2022)

The MEOPAeDent trial protocol—an observational study of the Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) effects in paediatric dentistry
por: Prud’homme, Tony, et al.
Publicado: (2019)

First results of the French OCTOPUS survey among festival attendees: a latent class analysis
por: Istvan, Marion, et al.
Publicado: (2023)

Two Cases of Hypersexuality Probably Associated with Aripiprazole
por: Cheon, EunJin, et al.
Publicado: (2013)

Subacute sclerosing panencephalitis presenting with hypersexual behavior
por: Manoj, S., et al.
Publicado: (2015)

Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics
por: Blum, Kenneth, et al.
Publicado: (2015)

Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics
por: Blum, Kenneth, et al.
Publicado: (2015)

A case of Klinefelter syndrome with hypersexual desire
por: Okolie, Kingsley, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_od1o0c4f88356lvkjs10inkk4m